Product Catalog


> Cytokine Function Cytokine Function
Cytokine function / Function of cytokine
Cytokines are a large group of proteins, peptides or glycoproteins that are secreted by specific cells of immune system. Cytokines are a category of signaling molecules that mediate and regulate immunity, inflammation and hematopoiesis. Cytokines are produced throughout the body by cells of diverse embryological origin. Cytokine is a general name; other names are defined based on their presumed function, cell of secretion, or target of action. For example, cytokines made by lymphocytes can also be referred to as lymphokines, while interleukins are made by one leukocyte and act on other leukocytes. And chemokines are cytokines with chemotactic activities. Cytokines may act on the cells that secrete them (autocrine action), on nearby cells (paracrine action), or in some instances on distant cells (endocrine action).
Cytokines generally function as intercellular messenger molecules that evoke particular biological activities after binding to a receptor on a responsive target cell.
Cytokine function table
Interleukin
| Cytokine | Cytokine Receptor |
Cytokine Source |
Cytokine Targets |
Cytokine Main Function |
Cytokine Disease Association |
| IL-1α; IL-1b | IL1RI and IL1R-AcP | Macrophages, many others | Macrophages, thymocytes, CNS, others | Inflammatory; promotes activation, costimulation, and secretion of cytokines and other acute-phase proteins; pyrogenic | ↑ = inflammatory bone resorption; gout; promotes Th17 response |
| IL-1ra (antagonist) | Soluble decoyreceptor: IL1RII and IL1R-AcP | IL-1ra and the soluble decoy receptor complex inhibit IL-1-mediated inflammatory responses | |||
| IL-2 | IL2Rα, IL2Rb, and IL2Rγ | T cells | T, B, NK cells, and macrophages | Proliferation; enhancement of cytotoxicity, IFNγ secretion, and antibody production | ↓ = lymphoproliferative disease and susceptibility to autoimmune disease; reduced Treg development. ↑ = reduced Th17 development. |
| IL-3 | IL3Rα and IL3Rb | T cells, mast cells, eosinophils | Hematopoietic progenitors, macro- phages, mast cells | Differentiation and survival of lymphoid and myeloid compartment | |
| IL-4 | IL4Rα and IL2Rγ or IL4Rα and IL13Ra1, IL13Ra2 | T cells, mast cells | T cells, B cells, macrophages, monocytes | Proliferation; differentiation of Th2; promotes IgG and IgE production; inhibits cell-mediated immunity and Th17 development | ↓ = susceptibility to extracellular pathogens and decreased response to allergens. ↑ = allergic asthma. |
| IL-5 | IL5Rα and IL3Rb | Th2 cells | Eosinophils, B cells | Proliferation and activation; hallmark of Th2 effector cells | ↓ = eosinophil and B-1 cell deficiency. ↑ = allergic asthma. |
| IL-6 | IL6Rα and gp130 | Macrophages, T cells, fibroblasts, and others | Wide variety of cells: B cells, T cells, thymocytes, myeloid cells, osteoclasts | Inflammatory and costimulatory action; induces proliferation and differentiation; synergizes with TGFb to drive Th17 | ↓ = deficient innate immunity and acute- phase responses, lymphopenia |
| IL-7 | IL7Rα and IL2Rγ | Thymic stromal cells, bone marrow, and spleen | B cells, T cells, thymocytes | Homeostasis, differentia- tion, and survival | ↓ = severe combined immune deficiency (SCID) |
| IL-9 | IL9R and IL2Rγ | T cells (Th2) | T cells, mast cells, neutrophils, epithelial cells | Proliferation; promotes Th2 cytokine secretion | |
| IL-10 | IL10R1 and IL10R2 | Differentiated T helper cells, Tregs, B cells, dendritic cells, others | Macrophages, T cells, dendritic cells, B cells | Immune suppression; decreases antigen presentation and MHC class II expression of dendritic cells; down- regulates pathogenic Th1, Th2, and Th17 responses | ↓ = immune pathology due to uncon- trolled inflammation. ↑ = inhibits sterile immunity to some pathogens. |
| IL-11 | IL11Rα and gp130 | Stromal cells | Hematopoietic stem cells, B cells, megakaryocytes | Proliferation | ↑ = exacerbates airway diseases |
| IL-12 (p35 + p40) | IL12Rb1 and IL12Rb2 | Macrophages, dendritic cells, B cells, neutrophils | T cells, NK cells | Differentiation and proliferation; promotes Th1 and cytotoxicity | ↓ = impaired Th1 responses and increased susceptibility to intracellular pathogens |
| IL-13 | IL13Ra1, IL13Ra2 and IL4Rα | T cells | B cells, macro- phages, others | Goblet cell activation in lung and gut; proliferation and promotion of IgE production; regulation of cell-mediated immunity | ↓ = impaired Th2 responses to extracel- lular pathogens and allergens. ↑ = exacerbates airway diseases. |
| IL-14 | Not defined | T cells | B cells | Promotion of B cell growth | |
| IL-15 | IL15Rα, IL2Rb, and IL2Rγ | Broad expression in hematopoietic cells | T cells, NK cells, epithelial cells, others | Proliferation and survival; cytokine production | ↓ = deficiency in NK cells and defective generation of memory T cells |
| IL-16 | Not defined | T cells, eosinophils, mast cells | CD4+ T cells | Recruitment of CD4+ T cells | |
| IL-17A | IL17RA or IL17RC | Th17 cells and others | Mucosal tissues, epithelial and endothelial cells | Proinflammatory; protective immunity in lung; tight junction integrity; promotes mobilization of neutrophils and cytokine production by epithelial cells; promotes angiogenesis | ↓ = susceptibility to extracellular pathogens ↑ = exacerbates organ- specific autoimmune inflammation |
| IL-17B | Intestine and pancreas | ||||
| IL- 17C | thymus and spleen | ||||
| IL-17D | T cells, smooth muscle cells, epithelial cells | ||||
| IL-17F | IL17RA or IL17RC | Th17 cells | Mucosal tissues, epithelial and endothelial cells | Similar function as IL-17A but with 2 logs lower receptor affinity | Not well defined. ↑ = increases neutrophil recruit- ment at high concentration. |
| IL-18 | IL18R and IL18-R-AcP | Macrophages, others | Th1 cells, NK cells, B cells | Proinflammatory; induction of IFNγ | ↓ = impairs Th1 responses |
| IL-19 | IL20R1 and IL20R2 | Monocytes, others | Keratinocytes, other tissues | Proinflammatory | ↑ = psoriasis |
| IL-20 | IL20R1 or IL22R1 and IL20R2 | Monocytes, others | Keratinocytes, other tissues | Proinflammatory | ↑ = psoriasis |
| IL-21 | IL21R and IL2Rγ | Differentiated T helper cells (Th2 and Th17 subsets) | T cells, B cells, NK cells, dendritic cells | Proliferation of T cells; promotes differentia- tion of B cells and NK cytotoxicity | |
| IL-22 | IL22R1 and IL10R2; IL22BP | Th1 and Th17 cells, NK cells | Fibroblasts, epithelial cells | Inflammatory, antimicrobial | ↑ = psoriasis |
| IL-23 (p19 + p40) | IL23R and IL12Rb1 | Macrophages and dendritic cells | T cells | Inflammatory; promotes proliferation of Th17 cells | ↓ = susceptibility to extracellular pathogens. ↑ = exacerbates organ- specific autoimmune inflammation. |
| IL-24 | IL20R1, IL22R1, IL20R2 | Monocytes, CD4+ T cells | Keratinocytes | ↑ = antitumor effects | |
| IL-25 (IL-17E) | IL17RB | Th2 cells, mast cells | Non-B, non-T, cKit+, FcεR− cells | Promotes Th2 differentiation and proliferation | ↓ = impairs Th2 responses to extracellular pathogens such as worms |
| IL-26 | IL22R1 and IL10R2 | Activated T cells | |||
| IL-27 (p28 + EBI3) | WSX-1 and gp130 | Activated dendritic cells | T cells, others | Induction of early Th1 differentiation by stimulating expression of the Tbet transcrip- tion factor; Inhibition of effector Th17 cel responses by inducing STAT-1-dependent blockade of IL-17 production | ↓ = immune pathology due to uncontrolled inflamma- tory response |
| IL-28A/B/IL29 (IFNλ family) | IL28R1 and IL10R2 | Activated subsets of dendritic cells? | May promote antiviral responses | ||
| IL-30 (p28 subunit of IL-27) | |||||
| IL-31 | IL31Rα and OSM-Rβ | Activated T cells | Myeloid progenitors, lung epithelial cells, keratinocytes | Proinflammatory | ↑ = atopic dermatitis; allergic asthma |
| IL-32 | Induces proinflammatory cytokine production | ||||
| IL-33 | ST2 and IL1R-AcP | Macrophages, dendritic cells | Mast cells, Th2 cells | Costimulation, promotes Th2 cytokine production | ↑ = atopic dermatitis, allergic asthma |
| IL-35 (p35 + EBI3) | Tregs | Effector T cells | Immune suppression |
Tumor Necrosis Factor (TNF)
| Cytokine | Cytokine Receptor |
Cytokine Source |
Cytokine Targets |
Cytokine Main Function |
Cytokine Disease Association |
| TNF alpha | Macrophages, monocytes, T cells, others | Neutrophils, macrophages, monocytes, endothelial cells | Inflammatory; promotes activation and production of acute-phase proteins | ↓ = disregulated fever; increased susceptibility to bacterial infection; enhanced resistance to LPS-induced septic shock ↑ = exacerbation of arthritis and colitis | |
| LT alpha | T cells, B cells | Many cell types | Promotes activation and cytotoxicity; development of lymph nodes and Peyer’s patches | ↓ = defective response to bacterial pathogens; absence of peripheral lymph nodes and Peyer’s patches | |
| LT beta | LTbR | T cells, B cells | Myeloid cells, other cell types | Peripheral lymph node development; proinflammatory | ↓ = increased susceptibility to bacterial infection; absence of lymph nodes and Peyer’s patches ↑ = ectopic lymph node formation |
| LIGHT | LTbR, DcR3, HVEM | Activated T cells, monocytes, DCs | B cells, NK cells, DCs, other tissue | Costimulatory; promotes CTL activity | ↓ = defective CD8 T cell costimulation |
| TWEAK | Fn14 | Monocytes, macrophages, endothelial | Tissue progenitors, epithelial, endothelial | Proinflammatory; promotes cell growth for tissue repair and remodeling | |
| APRIL | TACI, BAFF-R, BCMA | Macrophages, DCs | B cell subsets | Promotes T cell- independent responses; B cell homeostasis and differentiation | ↓ = impaired class switching to IgA |
| BAFF (BlyS) | TACI, BAFF-R, BCMA | Macrophages, DCs, astrocytes | B cells | B cell maturation and survival | ↓ = B cell lymphopenia; defective humoral immunity ↑ = SLE-like syndrome |
| TL1A | DcR3, DR3 | Macrophages, endothelial cells | Activated T cells | Promotes proliferation and cytokine production | GITRL |
| GITRL | GITR | DCs, macrophages, B cells, others | T regulatory cells, activated T cells | Costimulatory | |
| OX40L | OX40 | Activated T cells, B cells, DCs, monocytes | T cells, B cells, DCs | Costimulatory; activation and migration of monocytes | ↓ = impaired humoral responses |
| CD40L (CD154) | CD40 | T cells, monocytes, macrophages, others | B cells, APCs | Costimulatory; promotes T cell- dependent responses; B cell differentiation and class switching | ↓ = defective antibody responses and germinal center formation; hyper-IgM syndrome ↑ = SLE-like syndrome |
| FASL | FAS, DcR3 | Activated T cells, B cells, and NK cells | APCs, many other cell types | Regulatory; pro apoptotic | ↓ = lymphoproliferative disease and systemic autoimmunity |
| CD27L (CD70) | CD27 | Activated T cel s, B cells, DCs, monocytes | T cells, activated B cells | Costimulatory | |
| CD30L (CD153) | CD30 | Neutrophils, B cells, macrophages, activated T cells | T cells, B cells | Costimulatory; promotes proliferation and cytokine production | Viral CD30 blocks Th1 response |
| 4-1BBL | 4-1BB | Activated T cells, B cells, DCs, mono- cytes, macrophages | Activated T cells, B cells, DCs | Costimulatory; promotes activation and migration of monocytes | |
| TRAIL | TRAIL-R1 (DR4), R2 (DR5), R3 (DcR1), and R4 (DcR2) | Activated NK cells, T cells | Many cell types | Costimulatory; promotes NK cell functions; proapoptotic | ↓ = defective NK-mediated antitumor response ↑ = enhanced responsiveness to autoantigens |
| RANK Ligand (TRANCE) | RANK receptor or osteoprotegrin | T cells and osteoblasts | Osteoclasts, many cell types | Costimulatory; promotes osteoclasto- genesis and cytokine production | ↓ = osteopetrosis ↑ = osteoporosis |
Other Cytokines
| Cytokine | Cytokine Receptor |
Cytokine Source |
Cytokine Targets |
Cytokine Main Function |
Cytokine Disease Association |
| FLT3 Ligand | Receptor tyrosine kinases | Diverse tissue | DCs, other myeloid cells | Differentiation and proliferation; synergizes with stem cell factor | ↓ = impaired hematopoietic stem cell repopulation and B cell precursors |
| G-CSF | GCSFR dimer | Macrophages, fibroblasts, other tissues | Committed progenitors | Differentiation and activation of granulocytes | ↓ = neutropenia |
| GM-CSF | GM-CSFRα, βc | T cells, macrophages, fibroblasts, others | Macrophages, granulocytes, dendritic cells, and progenitors | Inflammatory; induction of activation; differ- entiation, growth, and survival | ↓ = affects alveolar function |
| IFNα, IFNβ, IFNω | IFNαR1, IFNαR2 | Macrophages, fibroblasts, plasmacytoid DCs, others | NK cells, many others | Promotes resistance to viral pathogens; promotes increased expression of MHC class I | ↓ = impaired antiviral responses |
| IFNγ | IFNγR1, IFNγR2 | Th1 cells, NK cells, CD8 T cells | Macrophages, NK cells, T cells, others | Promotes activation of APCs and cell-mediated immunity; increased MHC class II expression | ↓ = susceptibility to intracellular pathogens |
| LIF | LIFR, gp130 | Macrophages, T cells, fibroblasts, uterus, others | Embryonic stem cells, hematopoietic cells, others | Cell survival | ↓ = deficient hematopoietic progenitor cells; defective blastocyst implantation |
| M-CSF | Receptor tyrosine kinases | Monocytes, fibroblasts, others | Committed myeloid progenitors | Differentiation; prolifera- tion and survival | ↓ = monocyte deficiency; osteopetrosis |
| MIF | CD74 trimer, CD44 | Macrophages, T cells | Macrophages | Cell migration, DTH response | ↓ = susceptibility to Gram-negative bacteria |
| OSM | LIFR or OSM- Rβ, gp130 | Macrophages, fibroblasts, others | Myeloid cells, embryonic stem cells, T cells, others | Differentiation; induction of immune response (early) | |
| Stem Cell Factor (SCF) | Receptor tyrosine kinases | Bone marrow | Stem cells, mast cells | Activation and growth | ↓ = impaired hematopoietic stem cell proliferation and melanocyte production |
| TGFβ1, TGFβ2, TGFβ3 | TGFβR type I, type II, and type III | T cells, DCs, macrophages, others | All leukocyte populations | Regulatory; inhibits growth and activation; Treg maintenance; synergizes with IL-6 to promote Th17 | ↓ = increased susceptibility to autoimmune disorders ↑ = fibrotic diseases |
| TSLP Ligand | TSLPR, IL7Rα | Skin, lung, and gut | DCs and other myeloid cells | Promotes Th2 develop- ment (human); B cell development (mouse) | ↑ = atopic diseases |
References
- SnapShot: Cytokines I Cristina M. Tato and Daniel J. Cell 132, p. 324
- SnapShot: Cytokines II Cristina M. Tato and Daniel J. Cell 132, p. 500
- SnapShot: Cytokines III Cristina M. Tato and Daniel J. Cell 132, p. 900
- SnapShot: Cytokines IV Cristina M. Tato and Daniel J. Cell 132, p. 1062

+86-400-890-9989

